Predictive Value of Circulating miRNAs in Lymph Node Metastasis for Colon Cancer. Genes 2021, 12, 176

2.      In Hee Lee 1† , Soo Jung Lee 2† , Jeeyeon Lee 3 , Jin Hyang Jung 3 , Ho Yong Park 3 , Shin Young Jeong 4 , Sang-woo Lee 4 and Yee Soo Chae

Utility of 18 F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy.BMC Cancer (2020) 20:1106

3.      Lee IH, Kang BW, Kim JG, Bae WK, Ki MS, Park I, Jo JC, Kim JY, Koh SA, Lee KH, Cho YY, Ryoo HM, Kwak SG, Lee JL, Lee SA.

Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy. Korean J Intern Med. 2018 Oct 12. doi: 10.3904/kjim.2020.

4.      Lee IH, Kang K, Kang BW, Lee SJ, Bae WK, Hwang JE, Kim HJ, Park SY, Park JS, Choi GS, Kim JG.

Genetic variations using whole-exome sequencing might predict response for neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Med Oncol. 2018 Sep 11; 35 (11):145. doi: 10.1007/s12032-018-1202-8.

5.      IN HEE LEE, SOYOON HWANG, SOO JUNG LEE, BYUNG WOOG KANG. Baek D, Kim HJ, Park SY, Park JS, Choi GS, Kim JC, Cho SH, Kim JG.

Systemic Inflammatory Response After Preoperative Chemoradiotherapy Can Affect Oncologic Outcomes in Locally Advanced Rectal Cancer. ANTICANCER R ESEARCH 37: 1459-1466 (2017)

6.      In Hee Lee· Soo Jung Lee· Byung Woog Kang· Yee Soo Chae· Baek D, Hwang S, Kim HJ, Park SY, Park JS, Choi GS, Kim JC, Kim JG.

Pilot study of FMC (5
fluorouracil, mitomycin C, and cisplatin) with radiotherapy for patients with anal cancer. Cancer Chemother Pharmacol (2016) 78:1263
1267

7.      Lee IH, Lee JE, Byeon SW, Lee HJ, Huo SM, Yoon SB, Kim JS, Lee SH, Roh SY.

A  Case  of  Advanced  Gastric  Cancer  Presenting  as  Multiple  Colonic  Lymphoid  Hyperplasia. Korean J Gastroenterol. 2015 Oct; 66(4):221-6

8.      Lee SJ, Jeong JH, Lee IH, Lee J, Jung JH, Park HY, Lee DH, Chae YS.

Effect of High-dose Vitamin C Combined With Anti-cancer Treatment on Breast Cancer Cells. Anticancer Res. 2019 Feb;39(2):751-758

9.      Hwang GY, Baek DW, Cho HJ, Lee SJ, Chae YS, Kang BW, Lee IH, Kim JG, Seo AN, Bae HI, Park KB, Park JY, Kwon OK, Lee SS, Chung HY

Elevated Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Advanced Gastric Cancer Treated with Trastuzumab Combination Chemotherapy. Anticancer Res. 2018 May; 38 (5):3151-3156.

10.  Lee SJ, Jun SY, Lee IH, Kang BW, Park SY, Kim HJ, Park JS, Choi GS, Yoon G, Kim JG

CD274, LAG3, and IDO1 expressions in tumor-infiltrating immune cells as prognostic biomarker for patients with MSI-high colon cancer. J Cancer Res Clin Oncol. 2018 Jun; 144(6):1005-1014. doi: 10.1007/s00432-018-2620-x. Epub 2018 Mar 8.

11.  Sohn SK, Moon JH, Lee IH, Ahn JS, Kim HJ, Chung JS, Shin HJ, Park SW, Lee WS, Lee SM, Kim H, Lee HS, Kim YS, Cho YY, Bae SH, Lee JH, Kim SH, Song IC, Kwon JH, Lee YJ.

No benefit of hypomethylating agents compared to supportive care for higher risk myelodysplastic syndrome. Korean J Intern Med. 2017 Dec 15.

12.  Byung Woog Kang, Jong Gwang Kim, In Hee Lee, Han Ik Bae, An Na Seo.

Clinical significance of tumor-infiltrating lymphocytes for gastric cancer in the era of immunology. World J Gastrointest Oncol 2017 July 15; 9(7): 293-299

13.  Kim IH, Lee IH, Lee JE, Hong SH, Kim TJ, Lee KY, Kim YK, Kim SJ, Sung SW, Park JK, Yoo IR, Kim YS, Kim JO, Kang JH

Clinical Significance of C-MET Overexpression and Epidermal Growth Factor Receptor Mutation in Platinum-Based Adjuvant Chemotherapy Outcome in Surgically Resected Lung Adenocarcinoma. Ann Surg Oncol. 2017 Mar; 24 (3):770-777

14.  Kim IH, Lee IH, Lee JE, Hong SH, Kim TJ, Lee KY, Kim YK, Kim SJ, Sung SW, Park JK, Yoo IR, Kim YS, Kim JO, Kang JH

Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer .Clin Lung Cancer. 2016 Sep: 17 (5)

15.  Yoo Jin Lee & Sung Woo Park & In Hee Lee & Jae Sook Ahn & Hyeoung Joon Kim. Report on outcomes of hypomethylating therapy for analyzing prognostic value of  Revised International Prognostic Scoring System for patients with lower-risk myelodysplastic syndromes. Ann Hematol (2016) 95:1795
1804